Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Decibel Therapeutics logo

Decibel Therapeutics

Recent Finacing

Series D

Recent Raise

$82.2M

Decibel Therapeutics is a clinical-stage biotech developing gene therapies and precision therapeutics to restore inner-ear hair cell function, using single-cell genomics, cell-selective promoters, data-driven discovery, and delivery technologies.

Founded 2015
Massachusetts, United States
51-100
Publicly Traded
decibeltx.com

Highlights

Focus Areas

Biotechnology
Medical Device
Therapeutics

Recent Investors

SR One logo
Google Ventures logo
Third Rock Ventures logo
Foresite Capital logo
S-Cubed Capital logo
Samsara BioCapital logo
Surveyor Capital logo
Janus Henderson Investors logo
Casdin Capital logo
OrbiMed logo
BlackRock logo
Sobrato Capital logo

Financials

$189.2M

Total Raised

4

Funding rounds

16

Investors


Team

Upgrade to view the team

See the team members at Decibel Therapeutics.